Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab. Gupta A, Gonzalez-Rojas Y, Juarez E, Crespo Casal M, et al. N Engl J Med 2021 Oct 27. doi: 10.1056/NEJMoa2107934.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gupta A, Gonzalez-Rojas Y, Juarez E, Crespo Casal M, et al. Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab. N Engl J Med 2021 Oct 27. doi: 10.1056/NEJMoa2107934.
PMID: 34706189